- Home
- ACXP vs GROW Comparison
ACXP vs GROW Comparison
Compare ACXP & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- GROW
- Stock Information
- Founded
- ACXP 2017
- GROW 1968
- Country
- ACXP United States
- GROW United States
- Employees
- ACXP N/A
- GROW N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- ACXP Health Care
- GROW Finance
- Exchange
- ACXP Nasdaq
- GROW Nasdaq
- Market Cap
- ACXP 8.4M
- GROW 31.8M
- IPO Year
- ACXP 2021
- GROW N/A
- Fundamental
- Price
- ACXP $0.49
- GROW $2.46
- Analyst Decision
- ACXP Strong Buy
- GROW
- Analyst Count
- ACXP 2
- GROW 0
- Target Price
- ACXP $10.00
- GROW N/A
- AVG Volume (30 Days)
- ACXP 18.6M
- GROW 47.0K
- Earning Date
- ACXP 08-08-2025
- GROW 05-08-2025
- Dividend Yield
- ACXP N/A
- GROW 3.61%
- EPS Growth
- ACXP N/A
- GROW N/A
- EPS
- ACXP N/A
- GROW 0.01
- Revenue
- ACXP N/A
- GROW $8,932,000.00
- Revenue This Year
- ACXP N/A
- GROW N/A
- Revenue Next Year
- ACXP N/A
- GROW N/A
- P/E Ratio
- ACXP N/A
- GROW $233.35
- Revenue Growth
- ACXP N/A
- GROW N/A
- 52 Week Low
- ACXP $0.30
- GROW $2.02
- 52 Week High
- ACXP $3.33
- GROW $2.73
- Technical
- Relative Strength Index (RSI)
- ACXP 51.01
- GROW 56.66
- Support Level
- ACXP $0.46
- GROW $2.42
- Resistance Level
- ACXP $0.56
- GROW $2.68
- Average True Range (ATR)
- ACXP 0.10
- GROW 0.09
- MACD
- ACXP -0.01
- GROW -0.00
- Stochastic Oscillator
- ACXP 24.27
- GROW 42.11
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.